Last mentioned: Feb 24, 2026
Stock Listing
Shares expected to debut on the NSE and BSE exchanges.
Tentative Listing
Expected date for the shares to begin trading on the NSE and BSE.
Basis of Allotment
Finalization of share allotment expected for successful bidders.
Allotment Finalization
The basis of allotment is expected to be finalized for investors.
Final Bidding Day
The bidding process concludes with a 6.33% GMP trend.
Final Bidding Day
The window for all investor categories to place bids closes.
Final Bidding Day
Last day for investors to subscribe to the ₹125.22 crore issue.
Day 2 Milestone
Subscription reaches 3x overall with strong retail participation.
Day 2 Close
Subscription reaches 3x with strong retail participation.
IPO Opens
Public bidding commenced for retail and institutional investors.
IPO Opens
Gaudium IVF opens its initial public offering for subscription.
IPO Opens
Gaudium IVF opens its initial public offering for subscription.
Anchor Round
Gaudium IVF finalized anchor investor allocations ahead of the public open.
Gaudium IVF and Women Health's ₹125.22 crore IPO entered its final bidding day with a 3x overall subscription and a steady grey market premium. The offering, consisting entirely of a fresh issue, has seen particularly robust interest from retail investors as the company seeks to expand its fertility clinic network.
Gaudium IVF and Women Health's initial public offering has entered its final day of bidding with a 3.00x subscription rate and a 6.33% grey market premium. The issue has seen particularly strong interest from retail and non-institutional investors as the company seeks to expand its footprint in India's growing fertility market.
Gaudium IVF and Women Health has reached its final day of bidding with an overall subscription of three times as of the end of Day 2. The offering is seeing strong retail interest and maintains a 6.33% grey market premium, signaling a positive market debut.
Gaudium IVF and Women Health's initial public offering has reached its final day of bidding, showing robust investor interest with a 3x subscription rate by the end of Day 2. The offering is currently trading at a 6.33% premium in the grey market, reflecting positive sentiment toward the specialized fertility services sector in India.